Deus Technologies debuts lung cancer detector

Article

Deus Technologies will file for premarket approval of an x-ray CAD early-stage lung cancer detection system, joining a growing list of companies that are concentrating on this disease. The product will debut at the RSNA meeting.The stand-alone system,

Deus Technologies will file for premarket approval of an x-ray CAD early-stage lung cancer detection system, joining a growing list of companies that are concentrating on this disease. The product will debut at the RSNA meeting.

The stand-alone system, called RapidScreen RS-2000, uses image processing and feature extraction technology originally employed in the analysis of satellite remote-sensing images. It analyzes regions of interest that may have features associated with solitary pulmonary nodules.

The proprietary algorithms are based on a combination of image processing, neural network, and fuzzy logic techniques developed from a database of thousands of chest films of early-stage lung cancer and cancer-free cases.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.